【英伟达(NVDA.US)加持AI制药革命 SandboxAQ合成数据破解药物筛选难题】智通财经APP获悉,由谷歌母公司

智通财经
18 Jun
【英伟达(NVDA.US)加持AI制药革命 SandboxAQ合成数据破解药物筛选难题】智通财经APP获悉,由谷歌母公司Alphabet(GOOGL.US)分拆、获英伟达(NVDA.US)战略支持的AI初创企业SandboxAQ,于当地时间6月18日正式发布大规模合成数据集,旨在通过模拟药物分子与蛋白质的相互作用机制,加速全球新药研发进程。这家已累计融资近10亿美元的科技新贵,正试图打破传统实验室研究的时空限制,用算力重构药物筛选的底层逻辑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10